1. Home
  2. Neuromusculoskeletal Medicine Specialists Doctors in Milwaukee, WI
  3. Dr. Matthew M. Harmelink

Dr. Matthew M. Harmelink

Neuromusculoskeletal Medicine
Childrens Hospital Of Wisconsin
9000 W Wisconsin Ave, 
Milwaukee, WI 
Accepting New Patients

Childrens Hospital Of Wisconsin
9000 W Wisconsin Ave, 
Milwaukee, WI 
OverviewInsuranceLocationsClinical ResearchSimilar DoctorsFAQ

Overview

Matthew Harmelink is a Neuromusculoskeletal Medicine provider practicing medicine in Milwaukee, Wisconsin.

His clinical expertise encompasses Neurofibromatosis Type 1 (NF1).

He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 6 clinical trials. Dr. Harmelink is currently accepting new patients.

Specialties

Neuromusculoskeletal Medicine

Licenses

Pediatrics in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Children's Community Health
  • EPO
  • PPO
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Upper Peninsula Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
View 7 Less Insurance Carriers -

Locations

Childrens Hospital of Wisconsin
9000 W Wisconsin Ave, Milwaukee, WI 53226
Call: 414-266-3464

Additional Areas of Focus

Dr. Harmelink has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: March 10, 2026
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: November 18, 2025
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3
Open-Label Extension of the HOPE-2 Duchenne Muscular Dystrophy Trial
Open-Label Extension of the HOPE-2 Duchenne Muscular Dystrophy Trial
Enrollment Status: Active_not_recruiting
Publish Date: November 03, 2025
Intervention Type: Biological
Study Drug: CAP-1002 Allogeneic Cardiosphere-Derived Cells
Study Phase: Phase 2
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
Enrollment Status: Completed
Publish Date: July 08, 2025
Intervention Type: Genetic
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Intravenous Delivery of Allogeneic Cardiosphere-Derived Cells in Subjects With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of WVE-210201 With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (DYSTANCE 51)
A Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of WVE-210201 With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (DYSTANCE 51)
Enrollment Status: Terminated
Publish Date: May 20, 2021
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

16 Total Publications

Electrodiagnostic Studies as a Diagnostic and Prognostic Tool in Acute Flaccid Myelitis.
Electrodiagnostic Studies as a Diagnostic and Prognostic Tool in Acute Flaccid Myelitis.
Journal: Muscle & nerve
Published: August 04, 2025
View All 16 Publications
Similar Doctors
Dominic B. Fee
Expertise in
53
conditions
Dr. Dominic B. Fee
Neurology | Neuromusculoskeletal Medicine
Expertise in
53
conditions
Dr. Dominic B. Fee
Neurology | Neuromusculoskeletal Medicine
Referral may be required

Froedtert Hospital

900 N. 92nd St., 
Milwaukee, WI 
 (0.2 miles away)
414-805-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dominic Fee is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Milwaukee, Wisconsin. Dr. Fee is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA). Dr. Fee is board certified in Neurology, Electrodiagnostic Medicine, Clinical Neurophysiology, and Neuromuscular Medicine. Dr. Fee is currently accepting new patients.

David A. Shirilla
Expertise in
6
conditions
Dr. David A. Shirilla
Neurology | Neuromusculoskeletal Medicine
Expertise in
6
conditions
Dr. David A. Shirilla
Neurology | Neuromusculoskeletal Medicine
Referral may be required

Neuroscience Center – Specialty Clinics

900 N. 92nd St., 
Milwaukee, WI 
 (0.2 miles away)
414-805-5400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Shirilla is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Milwaukee, Wisconsin. Dr. Shirilla is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Shirilla is board certified in Neurology, Clinical Neurophysiology, and Neuromuscular Medicine. Dr. Shirilla is currently accepting new patients.

Richard T. Wlodarski
Expertise in
19
conditions
Dr. Richard T. Wlodarski
Neurology | Neuromusculoskeletal Medicine
Expertise in
19
conditions
Dr. Richard T. Wlodarski
Neurology | Neuromusculoskeletal Medicine
Referral may be required
📋Before you request

Endeavor Health Medical Group

920 Milwaukee Ave., Suite 2100, 
Lincolnshire, IL 
 (59.3 miles away)
847-570-2570
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Wlodarski, MD, a neurologist at Endeavor Health, specializes in neuromuscular medicine and cares for patients with myopathies, neuropathies and conditions like myasthenia gravis. He combines curiosity with evidence-based practice to offer patients clarity and treatment options tailored to their condition. Dr. Wlodarski is especially interested in advancing care through new, targeted therapies and disease-modifying treatments for previously untreatable neurological disorders. Dr. Wlodarski is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Peripheral Neuropathy, Orthostatic Hypotension, Familial Dysautonomia, and Low Blood Pressure. Dr. Wlodarski is board certified in American Board Of Psychiatry And Neurology. Dr. Wlodarski is currently accepting new patients.

VIEW MORE Neuromusculoskeletal Medicine Specialists

Frequently Asked Questions about Dr. Matthew M. Harmelink

How do I make an appointment with Dr. Matthew M. Harmelink?

You can book an appointment with Dr. Matthew M. Harmelink by calling their office at 414-266-3464. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

What conditions does Dr. Matthew M. Harmelink specialize in?

While Dr. Matthew M. Harmelink is a Neuromusculoskeletal Medicine, they have specific expertise in Neurofibromatosis Type 1 (NF1). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neuromusculoskeletal Medicine.

Does Dr. Matthew M. Harmelink participate in research or clinical trials?

Yes. Dr. Matthew M. Harmelink has published 16 articles and abstracts on conditions like Neurofibromatosis Type 1 (NF1). You can view a list of Dr. Matthew M. Harmelink's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Matthew M. Harmelink accept my insurance?

Dr. Matthew M. Harmelink accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 414-266-3464 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Harmelink's expertise for a condition
ConditionClose
          Want to save this doctor for later?
          Sign Up
          Is this your doctor?
          Find A Second Opinion
          Not sure about your diagnosis?
          Check Your Symptoms
           
           
           
           
          Learn about our expert tiers
          Learn More
          Are you the provider on this profile?
          Claim Profile
          For Patients
          • Our Story
          • How MediFind Works
          • Conditions A-Z
          • Doctor Directory
          • Symptoms Directory
          • Procedures Directory
          • Treatment Directory
          • Drug Directory
          • Infusion Center Finder
          • FAQ
          • Contact Us
          For Providers and Practices
          • Claim Your Profile
          • Newsroom
          Business Solutions
          • Provider
          • Network Solutions
          Additional Resources
          • Consumer Health Data Privacy Policy
          • Privacy Policy
          • Terms of Use
          • Advertising Policy
          • Content Policy
          Subscribe to our newsletter

          Sign up to stay informed about MediFind and get wellness sent your way.

          Close

            By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

            Bullet PinMediFind
            Follow us on
            This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
            © 2026 All Rights Reserved